Protecting IP in lab-grown organs – organoids

Lab-grown miniature organs (also known as organoids) is a technology area that has the potential to significantly lower costs and failure rates in drug development, and to improve safety.

G2/21 – Plausibility

A new EPO referral to the enlarged BoA will determine whether post-filed data can be used to support inventive step and plausibility.